|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 38 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$277,722 |
I/I |
20,850 |
1,253,084 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-10 |
4 |
B |
$19.48 |
$408,036 |
I/I |
20,934 |
3,690,370 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-06-11 |
4 |
OE |
$1.03 |
$21,738 |
I/I |
21,044 |
37,115 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$519,553 |
I/I |
21,221 |
6,087,950 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$430,371 |
I/I |
(21,445) |
25,983 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$469,825 |
I/I |
(21,633) |
47,428 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$651,092 |
I/I |
21,900 |
1,406,049 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$659,464 |
I/I |
22,071 |
8,235,908 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.32 |
$297,329 |
I/I |
22,322 |
1,731,311 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-01 |
4 |
B |
$13.78 |
$315,958 |
I/I |
22,380 |
288,767 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-21 |
4/A |
B |
$15.50 |
$348,611 |
I/I |
22,491 |
60,958 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-16 |
4 |
S |
$15.44 |
$348,832 |
I/I |
(22,545) |
1,833,904 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-05 |
4 |
B |
$19.50 |
$449,789 |
I/I |
22,939 |
1,173,043 |
2.25 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-04-03 |
4 |
S |
$0.11 |
$2,557 |
I/I |
(23,056) |
1,821,429 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-21 |
4 |
S |
$5.55 |
$128,235 |
I/I |
(23,100) |
2,251,147 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2012-02-01 |
4 |
B |
$17.00 |
$393,924 |
I/I |
23,172 |
116,454 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-22 |
4 |
B |
$4.05 |
$94,256 |
I/I |
23,244 |
3,188,435 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-02 |
4 |
B |
$3.70 |
$87,208 |
I/I |
23,576 |
3,734,541 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-16 |
4 |
B |
$34.46 |
$813,925 |
I/I |
23,621 |
243,405 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$186,231 |
I/I |
23,873 |
3,956,963 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-19 |
4 |
S |
$5.64 |
$135,841 |
I/I |
(23,875) |
191,967 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-19 |
4 |
B |
$13.25 |
$317,576 |
I/I |
23,968 |
43,108 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-16 |
4 |
B |
$27.24 |
$663,310 |
I/I |
24,256 |
6,590,213 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$486,842 |
I/I |
(24,259) |
233,034 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$308,642 |
I/I |
(24,383) |
575,768 |
0 |
- |
|
1397 Records found
|
|
Page 38 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|